Clinical Trials Directory

Trials / Completed

CompletedNCT01688323

Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer

Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

To look at what types of measures can be used to predict how an older person will tolerate chemoradiation treatment for head and neck cancer. This study uses surveys and a blood draw to look at the different measures.

Detailed description

Purpose: To identify baseline predictors of change in function over the course of treatment with chemoradiotherapy in patients with head and neck cancer. Participants: Patients 65 or older who have an appointment at the North Carolina Cancer Hospital (NCCH) or other participating sites, have planned chemoradiotherapy for head and neck cancer Procedures (methods): Consenting subjects will complete a Geriatric Assessment, Functional Assessment of Cancer Therapy - Head and Neck and give a blood sample for CBC and p16INK4a at the start of their chemoradiotherapy, at week four, at the end and 90 days post therapy. They will also complete a health behavior questionnaire at baseline.

Conditions

Interventions

TypeNameDescription
OTHERCollect Blood and Survey InstrumentsEach subject will be administered the appropriate surveys and blood draws over the course of the study.

Timeline

Start date
2012-07-01
Primary completion
2014-07-01
Completion
2016-05-01
First posted
2012-09-19
Last updated
2017-09-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01688323. Inclusion in this directory is not an endorsement.